ESR1 and breast carcinoma: In conclusion, we conducted a retrospective cohort study evaluating trends and survival outcomes between ALND and SLNB in patients with ER+ HER2− breast cancer with 3–5 positive lymph nodes who underwent adjuvant systemic and radiation treatment.